Sampo plc
16.2.2026 10:00:00 CET | Globenewswire | Press release
Trading in Sampo A shares on Nasdaq Stockholm has begun
Trading in Sampo A shares on Nasdaq Stockholm has begun
Sampo plc, press release, 16 February 2026 at 11:00 am EET
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS.
Trading in Sampo A shares on Nasdaq Stockholm has begun
The trading in Sampo A shares has begun on Nasdaq Stockholm today, 16 February 2026, under the short name (ticker) SAMPO SEK.
The Sampo A share has been listed on Nasdaq Stockholm through Swedish Depositary Receipts (SDRs) since 22 November 2022, with Svenska Enskilda Banken AB (publ) as the issuer of the SDRs and as a market maker and liquidity provider. In 2025, a policy change by Euroclear Sweden made it possible for Sampo to pursue a direct listing of the Sampo A share on Nasdaq Stockholm, replacing the SDR arrangement. Sampo’s application to delist its SDRs and to admit the trading of its A shares was approved by Nasdaq Stockholm on 28 January 2026.
The last day of trading in the SDRs was 13 February 2026. The conversion of the SDRs into A shares will be carried out automatically for all SDR holders. It does not require any action from the SDR holder. Underlying Sampo A shares will be automatically delivered to the same securities account as the SDRs are held on the record date, 17 February 2026. The A shares will be delivered to SDR holders on 19 February 2026.
A direct listing in the Swedish market will create a consistent Nordic presence across Nasdaq Helsinki, Nasdaq Copenhagen and Nasdaq Stockholm and will offer certain advantages for Sampo and its shareholders, including a smaller tick size on Nasdaq Stockholm compared with that applicable to the SDRs.
More information on the SDR conversion is available on Sampo’s IR blog: https://www.sampo.com/investors/ir-blog/sdr-conversion/.
SAMPO PLC
Investors Relations and Group Communication
For further information, please contact:
Mirko Hurmerinta
Interim Head of Investor Relations
tel. +358 10 516 0032
Distribution:
The principal media
www.sampo.com
IMPORTANT INFORMATION
None of the information contained herein constitute an offer to sell, or the solicitation of an offer to buy or acquire, any shares, SDRs, rights or other securities of Sampo in any jurisdiction whatsoever, including but not limited to, Finland, Sweden, and other member states of the European Economic Area. The information contained herein has been furnished solely for the purpose of communicating about the termination of the SDR arrangement and the concurrent Listing.
The information contained herein is not an offer for sale of securities in the United States. The shares, SDRs, rights or other securities of Sampo referred to have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration thereunder.
The information contained herein is not intended for, and must not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or Switzerland, and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any shares, SDRs, rights or other securities of the Sampo in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or Switzerland or any other country in which it would be contrary to the laws and regulations of that country.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Norvault23.10.2026 16:29:06 CEST | Press release
NORVAULT AG extends Bacon Series 001 offer and tender timetable
XBiotech Inc.23.10.2026 15:17:07 CEST | Press release
XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers
Precede Biosciences, Inc.23.10.2026 15:15:00 CEST | Press release
Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer
Golar LNG23.10.2026 14:16:21 CEST | Press release
Golar releases 2025 Environmental, Social and Governance report
Novartis Pharma AG23.10.2026 13:30:00 CEST | Press release
Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom